
1 Stock to Buy Now That Could Make You Rich in 2023
Published on November 23, 2022
Biopharmaceutical major Bristol-Myers Squibb Company (BMY) beat the consensus earnings and revenue estimates in the third quarter. Given its strong product pipeline, strategic acquisitions, discounted valuation, high profitability, strong financials,...
